Key facts
- Notable investors include Battle Born Venture, Reno Seed Advisors.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Dayamed
- ·The full record, as it builds
Funding rounds
No funding rounds for Dayamed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dayamed
Developer of a medication management platform designed to help manage patients' prescriptions. The company's platform offers to analyze patient health data, medication regimens, and remote patient monitoring, enabling patients to connect with health teams for personalized care.
- Sector
- Healthcare
- HQ
- Reno, NV, United States
- Founded
- 1996
- Employees
- 19
- Website
- dayamed.com/
- Ownership
- Privately Held (backing)
Dayamed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dayamed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dayamed in its N-PORT filings yet. We sweep new filings monthly.